Dr. Sushil Kumar is a Research Assistant professor at the Oregon Health & Science University (OHSU), Portland Oregon. He obtained his PhD from Max Planck Institute for biochemistry, Munich Germany where he worked in supervision of Prof. Axel Ullrich for studying cancer cell signaling. He did his postdoctoral work in Prof. Reto Schwendener’s laboratory at University of Zurich where he developed liposomal drugs for targeted delivery of payloads to macrophages as novel cancer therapy approach. He joined OHSU in 2012 in Prof. Lisa Coussens' laboratory where he has continued his research for studying cancer inflammation and developing immunotherapeutic approaches for cancer. He is employing ex vivo as well as mouse models for understanding immune cell phenotype for analyzing their role in cancer progression and developing novel therapeutics as well as biomarkers for cancer.
1997: PhD Cancer Research Centre of the Russian Academy of Medical Sciences, Moscow.
1997-2001: Postdoc at the University of Regensburg
2001-2007: Junior group leader/PI and lecturer, University of Heidelberg.
2007- 2010:Senior group leader/PI and senior lecturer, University of Heidelberg
2010-2013: Professor, head of the Lab for Cellular and Molecular Biology of Innate Immunity;
2013-permanent: Professor, head of Department for Innate Immunity and Tolerance, University of Heidelberg.
Professor of Experimental Rheumatology, University Medical Centre Utrecht. Manager of research and head of research laboratory of the department of Rheumatology & Clinical Immunology, UMCU. In addition to organization, initiation, and facilitation research of the department, there is a personal interest in a unique treatment of severe osteoarthritis being joint distraction, and in a unique animal model of osteoarthritis being the canine Groove model.
After graduating from the veterinary program at the University of Bristol, U.K., with honors, Dr. Lascelles completed a PhD in aspects of pre-emptive/perioperative analgesia at the University of Bristol. After an internship there, he completed his surgical residency at the University of Cambridge, U.K. and then a Fellowship in Oncological Surgery at Colorado State University. He is currently Professor in Small Animal Surgery and Pain Management at North Carolina State University.
Professor of Toxicology and Occupational Medicine at the Catholic University of Louvain and Director of the Louvain Centre of Toxicology and Applied Pharmacology in Brussels, Belgium.
Ashham Mansur is an Associate Professor of Anesthesiology. He is a Senior Consultant Anesthesiologist and has received his training at the University Medical Center Goettingen, Germany. His research focuses on sepsis and sepsis-related organ failure. He is also working with internationally recognized experts on integrative projects in order to facilitate precision medicine approaches in treatment of critically ill patients.
Interested in metabolomics and genomics of diseases! My current work is focused on generating quality metabolomics datasets leveraging the high-resolution mass-spectrometry (GC-Orbitrap-MS and LC-Orbitrap-MS) and occasionally NMR datasets to combine with other -omics layers such as genomics (transcriptomics, epigenetics), proteomics, and clinical data sets to provide insights in metabolic changes that are associated with human and non-human primate wellness and disease conditions, specifically metabolic syndromes such as atherosclerosis, diabetes, obesity, and Alzheimer’s disease.
Professor of Oral Biology in the Medical Faculty at the University of Zurich, Switzerland since 2006. Research in the fields of stem cells, genetics, molecular and experimental biology related to orofacial developmental and regeneration processes.
DDS degree from the Dental Faculty of the Kapodistrion University of Athens (Greece), Master degree for Immunology, Genetics and Differentiation, and PhD in Developmental Biology from the University of Lyon (France). Postdoctoral studies at the University of Helsinki (Finland), Karolinksa Nobel Institute (Stockholm, Sweden) and Yale University (USA). Previously Professor at the Mediterranean University (Marseilles, France), Visiting Professor at the Ecole Normale Superieure of Lyon (France), Clinical Senior Lecturer at King's College London (UK), Visiting Professor at the Polytechnic University of Marche (Ancona, Italy), Visiting Professor at the Second University of Napoli (Napoli, Italy). Chief-Editor of the “Frontiers of Craniofacial Biology and Dental Research”, Associate Editor of “Stem Cell Research”, Scientific Editor of “European Cells & Materials”, and part of the editorial board in additional 8 scientific journals. More than 110 original articles in journals such as “Journal of Cell Biology”, “Development”, “Developmental Biology”, “Nature Genetics”, “Science Signaling”, “Scientific Reports”, “Frontiers in Physiology” and more than 200 keynote and invited lectures.
Alessandra Montecucco heads a laboratory of the Unit of Molecular and Cellular Biology of the Nucleus at the Institute of Molecular Genetics (IGM) of the Italian National Research Council (CNR). Her research activity is focused on the cellular response to DNA damage and genome integrity.
- Executive Vice President and Associate Center Director for Translational Research
- Michael McGillicuddy Endowed Chair for Melanoma Research and Treatment
- Co-Director of the Donald A. Adam Comprehensive Melanoma Research Center at the Moffitt Cancer Center.
Dr. Mulé is recognized for his research and clinical contributions to cancer immunotherapy, particularly in solid tumors. He has published nearly 200 articles in the areas of cancer vaccines and cancer immunotherapy; and he has been an NCI-NIH investigator continuously for nearly 20 years.
Dr. Mulé serves on the advisory board of M2Gen, a wholly-owned subsidiary of the Moffitt Cancer Center in the area of personalized medicine in oncology, which he helped to establish; the Board of Directors of Medicine in Need, Cambridge, MA (a non-profit spin-out of Harvard University, and selected as a 2011 Technology Pioneer by the World Economic Forum); and the advisory boards of several NCI-designated Cancer Centers and was a member of the NCI Director’s Board of Scientific Counselors (BSC-A, clinical), remaining a long-standing special government employee to the FDA and the NCI; the scientific/medical advisory boards of several private and public companies where he also served as a consultant; and he chaired the FDA’s CBER Cellular, Tissue, and Gene Therapy Advisory Committee.
I am a Computer Research Scientist in the Environmental Genomics and Systems Biology division at Lawrence Berkeley Laboratory. My work focuses on computational methods for representing and interpreting complex biological data, in particular through the development and application of knowledge representation structures such as ontologies.
Cardiologist, Scripps Clinic; Assistant Professor, Scripps Translational Science Institute; Visiting Scholar, University of California - San Diego. Judge, Qualcomm Tricorder XPRIZE; Fellow of the American College of Cardiology. M.D., PhD. - Albert Einstein College of Medicine; M.C.T.I.- The Scripps Research Institute.